Softwr

Healthcare · head to head

Lunit vs PioneerRx

Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite
PioneerRx logo

PioneerRx

Healthcare

Pharmacy management system built for independent community pharmacies

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.; PioneerRx pricing is not published, and total cost including hardware, interfaces and training is substantially above the monthly software figure
  • They diverge on capability: Lunit covers Lunit INSIGHT MMG, PioneerRx covers Prescription workflow.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Lunit and PioneerRx actually diverge.

Attributes where Lunit and PioneerRx differ
AttributeLunitPioneerRx
PlatformsWebWindows, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

Only in PioneerRx

  • Prescription workflow
  • Claims adjudication
  • Medication synchronisation
  • Clinical services
  • Inventory management
  • Patient communication

What people use each for

The jobs each tool is most often brought in to do.

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot PioneerRx
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot PioneerRx
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot PioneerRx
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot PioneerRx

PioneerRx

  • Independent community pharmacies competing with chains on servicenot Lunit
  • Pharmacies building revenue from clinical services rather than dispensing margin alonenot Lunit
  • Operations running medication synchronisation and adherence packagingnot Lunit
  • Multi-location independents needing consistent workflow across storesnot Lunit

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

PioneerRx

  • Pricing is not published, and total cost including hardware, interfaces and training is substantially above the monthly software figure
  • It is a Windows-centric system with a traditional interface, which shows against newer cloud entrants
  • More capability than a very low-volume pharmacy needs, and that capability has to be configured and learned
  • Switching pharmacy systems is disruptive because dispensing cannot pause, so migration planning matters more than in most software categories
  • US-only, with no relevance outside that regulatory and insurance environment

Pricing, plan by plan

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

PioneerRx

On request
  • PioneerRx$undefined/month
    • Prescription processing
    • Claims adjudication
    • Inventory

Which should you pick?

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Choose PioneerRx if

  • You need prescription workflow.
  • You work on Windows, Web.
  • You also want claims adjudication.
PioneerRx review

Questions people ask

Is Lunit or PioneerRx better?
Neither clearly leads. Lunit starts at On request and PioneerRx at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Lunit or PioneerRx?
Lunit starts at On request and PioneerRx at On request.
Does Lunit or PioneerRx run on more platforms?
Lunit runs on Web. PioneerRx runs on Windows, Web.
What is Lunit best used for?
Lunit is most often used for a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated, a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically, an american breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what volpara is bought for, a tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise films. Of those, a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated and a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically are not what PioneerRx is typically brought in for.
What can Lunit do that PioneerRx cannot?
Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment. PioneerRx covers Prescription workflow, Claims adjudication, Medication synchronisation, Clinical services.

Answered from the vendors’ own pages

Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

PioneerRx: Who is PioneerRx for?

Independent community pharmacies in the United States, explicitly. Its development priorities target the things that help an independent compete with a chain.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

PioneerRx: What does it cost?

Not published. Expect a monthly software fee plus hardware, interface and training costs, and ask for the total rather than the headline.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

PioneerRx: Why do clinical services matter so much?

Dispensing margin has been compressed for years. Immunisations, medication therapy management and point-of-care testing are where independents now make money, so the software support for documenting and billing them is a commercial question rather than a feature preference.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

PioneerRx: How disruptive is switching?

Meaningfully. A pharmacy cannot stop dispensing during a migration, so data conversion, staff training and a cutover plan need real preparation.

PioneerRx: Does it work outside the US?

No. It is built around US insurance adjudication and regulatory requirements.

Share

Related pages

More on Lunit

More on PioneerRx

Keep looking

Other head to heads